Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy

Chinese Medical Journal

Volumn 117, Issue 2, 2004, Pages 296-298

  Jiang, Teng Yong ^a   Wu, Xue Si ^a   Lu, Qiang ^a   Meng, Xu ^a   Jia, Chang Qi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiomyopathy; Catheter ablation; Hypertrophic; Surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART SURGERY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; PERIOPERATIVE PERIOD; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHILD; FOLLOW-UP STUDIES; HEART SEPTUM; HUMANS; MIDDLE AGED;

EID: 1542791391     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kuhn H, Gietzen F, Schäfers M, et al. Changes of left ventricular outflow tract after transcoronary ablation of septum hypertrophy ( TASH ) for hypertrophic obstructive cardiomyopathy as assessed by transesophageal echocardiography and measuring of myocardial glucose utilization and perfusion. Eur Heart J 1999;20:1808-1817.
2. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septum hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 1342-1354.
3. Boekstegers P, Steinbigler P, Molnar A, et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:846-853.
4. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long-term follow up of the first series of 25 patients. Heart 2000;83:326-331.
5. Jiang TY, Wu XS, Jia CQ, et al. Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy. Chin Med J 2002;115:26-30.
6. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
7. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
8. Minami K, Woltersdorf H, Kleikamp G, et al. Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological and hemodynamic aspects. J Cardiovasc Surg (Torino) 2000;41: 801-806.
9. Seggewiss H, Fabler L, Gleichman U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 1999;47:94-100.
10. Kuhn H, Gietzen FH, Leuner C, et al. Transcoronary ablation of septal hypertrophy (TASH): A new treatment option for hypertrophic obstructive cardiomyopathy. Z Cardiol 2000;89:IV41-IV54.
11. Bircks W, Schulte HD. Surgical treatment of hypertrophic obstructive cardiomyopathy with special reference to complications and to atypical hypertrophic obstructive cardiomyopathy. Eur Heart J 1983;4(Suppl):187-190.